NIH Helps Scientists Sleuthing for Clues in the Human Genome



The National Institutes of Health (NIH) is taking a leadership role in a new research approach that involves scanning the human genome looking for variations, or markers, that raise the risk of disease. Results of these genome-wide association studies (GWAS) are being posted in a database accessible to qualified researchers and will be used to come up with better detection, treatment, and prevention strategies, says Emily Harris, PhD, epidemiologist in the new Office of Population Genomics within the NIH's National Human Genome Research Institute.

Until completion of the Human Genome Project about five years ago, GWAS weren't even possible. The latest, whole-genome genotyping technology has now made them more financially feasible to carry out, says Harris.

The markers chosen are relatively common in the general population, "five percent or higher," to keep sample sizes manageable, says Harris. "We want to find the location [of genetic variations], not necessarily the gene itself." Follow-up studies can further narrow the search to suspect genes, what the genetic variations do, and how they relate to disease risk changes.

Results of GWAS are to be a "community resource," says Harris. It's not just a cost issue. "NIH wants to encourage investigators to share data more quickly and broadly, and...new statistical methods are available to better elucidate some associations."

The results of 14 GWAS are currently available through the Database of Genotype of Phenotype (dbGaP) that was created last year by the National Center for Biotechnology Information, a part of the NIH's National Library of Medicine, says Harris.

Data from the 9,000-participant Framingham Genetic Research Study is also being shared through dbGaP, says Harris. Information from another eight studies under the NIH's Genes, Environment and Health Initiative (GEI) will be added starting later this year.

GWAS are more like epidemiological studies than traditional clinical research in that they look for clues to disease among large populations, says Harris. The clues form the basis of subsequent research on different, increasingly targeted patient groups. But first, researchers want to ensure they aren't following "false clues" by replicating results across several like studies.

The end goal for the Office of Population Genomics is to facilitate the application of genomic knowledge to health. Currently, the eight-employee Office is providing leadership to GAIN and GEI and helping to cross-educate epidemiologists and geneticists, says Harris. It is involved with projects to improve statistical methods as well as explore the use of electronic medical records and associated bio-repositories in population-based studies.

Once a disease's "causal variant" has been identified, the Office will begin funding studies looking at the distribution of that disease and variant in the population, says Harris.  To ensure consistency, the Office will be developing a "toolkit" regarding how to measure ethnicity, blood pressure, height, and other phenotypic data. "The other purpose is to look at the different ways people measure things and see if they can be combined in a way that makes sense so we have some harmonization between data [already and yet to be] collected."

The chief computational challenge of GWAS is how to collectively analyze genetic variations and non-genetic factors, like environment and family history, "to understand what is really going on in the data and biologically," says Harris. "Now, we tend to analyze each marker one at a time."
-----------------------
This article first appeared in Bio-IT World’s eCliniqua newsletter. Click here for a free subscription to eCliniqua.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .